Gil Hyun-Il, Lee Taebum, Jeong Byeong-Ho, Lee Hyun, Choe Junsu, Ahn Kangmo, Hong Sang Duk, Jeon Kyeongman, Koh Won-Jung, Kim Jung-Sun, Park Hye Yun
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
J Thorac Dis. 2019 Mar;11(3):839-847. doi: 10.21037/jtd.2019.02.24.
Transmission electron microscopy (TEM) is one of diagnostic tests for primary ciliary dyskinesia (PCD). The mucosal samples obtained for cilia examination are generally procured from the nasal turbinate, but these specimens often yield inadequate results. The bronchial mucosa is recognized as an alternative sample, but no study has examined the additional utility of bronchial mucosa compared with nasal mucosa in the diagnosis of PCD.
The medical records of 96 patients who underwent TEM for suspected PCD between April 1997 and June 2017 were reviewed. Patients were divided into three groups based on the site of mucosal biopsy: nasal biopsy (NB) group with nasal mucosal biopsy only; bronchial biopsy (BB) group with bronchial mucosal biopsy only; and nasal and bronchial biopsy (NBB) group with a combination of nasal and bronchial mucosal biopsies.
The rate of PCD diagnosis was 28.8% (17/59) in the NB group, 41.2% (7/17) in the BB group, and 60.0% (12/20) in the NBB group. The yield of PCD diagnosis significantly increased in the NBB group compared with the NB group (P=0.012). In the NBB group, 25.0% (5/20) of patients were diagnosed with PCD by nasal mucosal biopsy, and 35.0% (7/20) of patients were additionally diagnosed by bronchial mucosal biopsy. The presence of sinusitis or bronchiectasis was not associated with prediction of PCD diagnosis from nasal or bronchial mucosal biopsy.
The combination of nasal and bronchial mucosal biopsy for TEM showed higher yields of PCD diagnosis than nasal mucosal biopsy alone.
透射电子显微镜检查(TEM)是原发性纤毛运动障碍(PCD)的诊断测试之一。用于纤毛检查的黏膜样本通常取自鼻甲,但这些标本的结果往往不理想。支气管黏膜被认为是一种替代样本,但尚无研究探讨支气管黏膜相对于鼻黏膜在PCD诊断中的额外效用。
回顾了1997年4月至2017年6月期间因疑似PCD接受TEM检查的96例患者的病历。根据黏膜活检部位将患者分为三组:仅进行鼻黏膜活检的鼻活检(NB)组;仅进行支气管黏膜活检的支气管活检(BB)组;以及同时进行鼻和支气管黏膜活检的鼻和支气管活检(NBB)组。
NB组的PCD诊断率为28.8%(17/59),BB组为41.2%(7/17),NBB组为60.0%(12/20)。与NB组相比,NBB组的PCD诊断率显著提高(P=0.012)。在NBB组中,25.0%(5/20)的患者通过鼻黏膜活检被诊断为PCD,另外35.0%(7/20)的患者通过支气管黏膜活检被诊断。鼻窦炎或支气管扩张的存在与通过鼻或支气管黏膜活检预测PCD诊断无关。
联合鼻和支气管黏膜活检进行TEM检查显示出比单独鼻黏膜活检更高的PCD诊断率。